News & Updates

People with lower muscle mass and grip strength are at increased risk of developing severe nonalcoholic fatty liver disease (NAFLD), reveals a study.

Counselling for alcohol dependence and abuse can help reduce the 30-day readmission rates for alcoholic hepatitis (AH), according to a study presented at the recently concluded 2022 Digestive Disease Week (DDW 2022).

A team of Singapore-based researchers has identified two blood biomarkers that not only predict clinical response to immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) patients but also the incidence of side effects from the same treatment.

Use of aspirin in the long term appears to markedly reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV), a study has shown.

Administration of oral silymarin leads to a substantial decrease in hepatotoxicity severity after 1 month of treatment in nonmetastatic breast cancer patients on doxorubicin/cyclophosphamide-paclitaxel (AC-T) regimen, reports a study.